Related references
Note: Only part of the references are listed.Clinical Features of Human Influenza A (H5N1) Infection in Vietnam: 2004-2006
Nguyen Thanh Liem et al.
CLINICAL INFECTIOUS DISEASES (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009
Vivek Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
Fatimah S. Dawood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation
Olive T. W. Li et al.
PLOS ONE (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten et al.
SCIENCE (2009)
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
Iain Stephenson et al.
EMERGING INFECTIOUS DISEASES (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults
Karin Levie et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
Nega Ali Goji et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity
James Stevens et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China
Hua Wang et al.
LANCET (2008)
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Jens Wrammert et al.
NATURE (2008)
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin
Aarthi Chandrasekaran et al.
NATURE BIOTECHNOLOGY (2008)
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Iain Stephenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture
Hartmut J. Ehrlich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sanae Sasaki et al.
PLOS ONE (2008)
Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
Tawee Chotpitayasunondh et al.
PLOS ONE (2008)
Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007
Xiu-Feng Wan et al.
PLOS ONE (2008)
Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
Zoltan Vajo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
Arun K. Kashyap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
Terry M. Nolan et al.
VACCINE (2008)
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007
Maryna Eichelberger et al.
VACCINE (2008)
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Hans C. Rumke et al.
VACCINE (2008)
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (HSN1) vaccine in infants and children
Terry Nolan et al.
VACCINE (2008)
Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses
John M. Nicholls et al.
RESPIRATORY RESEARCH (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity
Zhi-Yong Yang et al.
SCIENCE (2007)
Inactivated whole virus influenza A (H5N1) vaccine
Zoltan Vajo et al.
EMERGING INFECTIOUS DISEASES (2007)
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
Cameron P. Simmons et al.
PLOS MEDICINE (2007)
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract
J. M. Nicholls et al.
NATURE MEDICINE (2007)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Three Indonesian clusters of H5N1 virus infection in 2005
I. Nyoman Kandun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors
Shinya Yamada et al.
NATURE (2006)
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin et al.
LANCET (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
T cell responses are better correlates of vaccine protection in the elderly
JE McElhaney et al.
JOURNAL OF IMMUNOLOGY (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control
H Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Influenza type a virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2
D Zharikova et al.
JOURNAL OF VIROLOGY (2005)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High efficiency creation of human monoclonal antibody-producing hybridomas
SK Dessain et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
S Sambhara et al.
CELLULAR IMMUNOLOGY (2001)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
JJ Treanor et al.
VACCINE (2001)
Drug therapy: Prevention and treatment of influenza.
RB Couch
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
